Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,434.00    4.00 (0.09%)
Bid:
4,434.00
Ask:
4,436.00
Spread: 2.00 (0.045%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

22 May 2017 12:44

RNS Number : 8492F
Morgan Sindall Group PLC
22 May 2017
 

Morgan Sindall Group plc

('the Company')

 

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

2014 Long Term Incentive Plan (the 'Plan')

On 19 May 2017, the performance share awards granted to the executive directors on 19 May 2014 under the Plan vested following partial achievement of the performance conditions at 62.06%. The remainder of the award which has not vested has now lapsed. The PDMR's named below have each received shares in satisfaction of the award. These shares include additional shares representing the dividend equivalent to which they are entitled under the Plan rules. These shares were satisfied from market purchased shares held in the Morgan Sindall Employee Benefit Trust.

 

Both John Morgan and Steve Crummett disposed of sufficient of the vested shares to fund the tax and national insurance contribution (PAYE) payable in respect of them.

 

Name of Director

Number of performance shares awarded

19 May 2014

62.06% of performance share awards vesting

Number of dividend equivalent shares

Total number of shares vested

Number of shares disposed to satisfy the PAYE payable

 

 

 

Total number of shares transferred to the PDMR

Number of performance share awards lapsed

 

 

 

 

 

 

 

 

John Morgan

55,687

34,560

2,642

37,202

17,485

19,717

21,127

Steve Crummett

41,956

26,038

1,991

28,029

13,174

14,855

15,918

 

The closing mid-market price of a share on 19 May 2017 was £11.90 and the shares disposed to fund the PAYE payable were sold to the Morgan Sindall Employee Benefit Trust at that price.

 

Interests of Directors and PDMRs

As a result of the above transactions, the PDMRs hold the following interests (all of which are beneficial) in the share capital of the Company:

 

Name of Director

Beneficial interest in shares

 

% issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

 

 

 

 

 

John Morgan

4,524,069

10.12

106,364

264,943

Steve Crummett

29,470

0.07

-

206,921

 

The following disclosures are made in accordance with Article 19 of the Market Abuse Regulation.

 

 

1  

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Morgan 

2  

Reason for the notification  

a)

Position/status

Executive Director/PDMR 

b)  

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)  

LEI

2138008339ULDGZRB345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 ISIN: GB0008085614 

b)

 

Nature of the transaction

 

 

Vesting of conditional share awards under the Morgan Sindall Group 2014 Long Term Incentive Plan:

- 37,202 shares acquired at nil cost

- 17,485 shares sold to satisfy PAYE payable at £11.90 per share

c)

 

Price(s) and volume(s)

 

 

 

Price(s) 

Volume(s)

Shares:

Acquired £0.00

Sold £11.90

 

37,202

17,485 

 

d)

Aggregated information

 - Aggregated volume

- Price

As above 

 

 

e)

Date of the transaction

19 May 2017

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Steve Crummett 

2

Reason for the notification  

a)

Position/status

Executive Director/PDMR 

b)  

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)  

LEI

2138008339ULDGZRB345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 

ISIN: GB0008085614 

b)

 

Nature of the transaction

 

 

Vesting of conditional share awards under the Morgan Sindall Group 2014 Long Term Incentive Plan:

- 28,029 shares acquired at nil cost

- 13,174 shares sold to satisfy PAYE payable at £11.90 per share

c)

 

Price(s) and volume(s)

 

 

 

Price(s) 

Volume(s)

Shares:

Acquired £0.00

Sold £11.90

 

28,029

13,174 

 

d)

Aggregated information

 - Aggregated volume

- Price

As above 

 

 

e)

Date of the transaction

19 May 2017

f)

Place of the transaction

Outside a trading venue

 

Enquiries:

 

Clare Sheridan Tel: 020 7307 9200

Company Secretary

 

22 May 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFSLEIIFFID
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.